Financhill
Back

BeiGene 10K Form

Buy
75

BEIGF
BeiGene

Last Price:
14.40
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BEIGF News And Ratings

See the #1 stock for the next 7 days that we like better than BEIGF

BEIGF Financial Statistics

Sales & Book Value

Annual Sales: $2.46B
Cash Flow: $54.71M
Price / Cash Flow: 0
Annual Sales: $2.49
Price / Book: 6.25

Profitability

EPS (TTM): -0.64000
Net Income (TTM): $-860.46M
Gross Margin: $2.08B
Return on Equity: -24.64%
Return on Assets: -15.07%

BeiGene Earnings Forecast

Key BeiGene Financial Ratios

  • The Gross Profit Margin over the past 9 years for BEIGF is 84.55%.
  • The Selling, General & Administrative Expenses for BEIGF have been equal to 61.19% of Gross Profit Margin.
  • The Research & Development expenses have been 72.34% of Revenue.
  • The Interest Expense is -42.10% of Operating Income.
  • The Net Earning history of BEIGF is -35.86% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

BeiGene Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: BEIGF
Website: beigene.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 1.93
Quick Ratio: 1.63

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BEIGF Technical Analysis vs Fundamental Analysis

Buy
75
BeiGene (BEIGF) is a Buy

Is BeiGene a Buy or a Sell?

  • BeiGene stock is rated a Buy
    The current BeiGene [BEIGF] share price is $15.50. The Score for BEIGF is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.